Alexander Johnson, MD
Hematology & Oncology · Bismarck, NDNPI 1275055956
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations.
Across 39 payments — averaging $38.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novocure Inc.$195
- Sanofi$171
- Novartis$132
- Blueprint Medicines Corporation$128
- Pfizer$114
- Eisai Inc.$103
- plus $655 from 18 others
What the payments were for
- Food & beverage$1,48299%
- Education$161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novocure Inc. | 2 | $195 |
| Sanofi | 2 | $171 |
| Novartis | 5 | $132 |
| Blueprint Medicines Corporation | 1 | $128 |
| Pfizer | 2 | $114 |
| Eisai Inc. | 1 | $103 |
| ADC Therapeutics America, Inc. | 1 | $101 |
| Sanofi-aventis U.S. LLC | 1 | $96 |
| Johnson & Johnson | 4 | $69 |
| Merck | 2 | $59 |
| AbbVie | 3 | $50 |
| Lilly USA, LLC | 2 | $47 |
| Seagen Inc. | 2 | $36 |
| Pharmaessentia USA Corporation | 1 | $22 |
| Bristol Myers Squibb | 1 | $22 |
| Beigene USA, Inc. | 1 | $21 |
| Deciphera Pharmaceuticals Inc. | 1 | $20 |
| Taiho Oncology, Inc. | 1 | $19 |
| Geron Corporation | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Legend Biotech USA Inc. | 1 | $16 |
| Rigel Pharmaceuticals, Inc. | 1 | $15 |
| Ipsen Biopharmaceuticals, Inc | 1 | $14 |
| Foundation Medicine, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AYVAKIT$128
- NovoTTF-100L$107
- LENVIMA$103
How this compares
$1,498 in reported general payments places this provider in the 65th percentile of 35 hematology & oncology providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abiraterone Acetate | 67 | $155,436 |
| Imatinib Mesylate | 12 | $36,406 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 48 | $1,090 |
| Anastrozole | 59 | $862 |
| Dexamethasone | 86 | $819 |
| Ondansetron Hcl | 61 | $517 |
| Oxycodone Hcl | 20 | $409 |
| Prednisone | 81 | $261 |
| Pregabalin | 21 | $241 |
| Letrozole | 15 | $212 |
| Hydroxyurea | 18 | $206 |
| Acyclovir | 17 | $198 |
| Potassium Chloride | 12 | $184 |
| ValacyclovirValacyclovir Hcl | 11 | $176 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 17 | $164 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Bismarck
- Peter KurnialiBismarck$8K
- Matthew McGeeBismarck$3K
- Thandiwe GrayBismarck$2K
- Stewart SharpBismarck$2K
- Sagar RakshitBismarck$2K
- John ReynoldsBismarck$2K
- Edward WosBismarck$1K
- Aaron LuebkeBismarck$829
- David Oladele-BankoleBismarck$16
- Baruti SerabeBismarck$14
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.